Exchange: NASDAQ·Updated 04:16 PM EDT
MBIO logo

MBIO Mustang Bio Inc

$0.5417
$0.0171
(3.05%)
Today
Closed $0.5429
$0.0012
(0.22%)
After Hours
Reported EarningsAug 12
Mkt Cap$4.24M
Vol37,377.00

About MBIO

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the translation of medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline includes CAR T therapies for hematologic malignancies, CAR T therapies for solid tumors, and gene therapies for rare genetic disorders. The company was founded on March 13, 2015 and is headquartered in Waltham, MA.
50

Neutral Sentiment

How do you feel about MBIO?

Advertisement|Remove ads.